Non-CDL

Diagnosed with Fibromyalgia — Your Medical Aid Questions Answered

Fibromyalgia is a condition where the medical aid system is often poorly aligned with patient needs. There is no CDL registration, no dedicated benefit, and the allied health services that are most beneficial are the most likely to hit benefit limits. This guide addresses what your plan does cover and how to get the most from it.


Does My Medical Aid Have to Cover This?

Partially. Fibromyalgia is not a CDL condition and has no standalone PMB benefit. Your scheme is not legally obligated to fund a specific fibromyalgia treatment programme. However:

The challenge is not whether these are covered — it is that they are often covered up to limited annual totals that are rapidly exhausted.


Managing Medications on Non-CDL Benefits

Because fibromyalgia is not on the CDL, medications are not funded from a protected chronic benefit. They are funded from:

If you are on duloxetine or pregabalin long-term, check whether your plan has an ATB and what the annual threshold for accessing it is. On entry-level plans without an ATB, medications may become fully self-funded once MSA is exhausted.


Making the Most of the Psychology Benefit

Cognitive behavioural therapy (CBT) is the most evidenced psychological intervention for fibromyalgia. Most plans allow 10–20 psychology sessions per year under the mental health outpatient benefit. For a full CBT programme for fibromyalgia, 16–20 sessions may be required.

Practical strategies: - Begin CBT early in the benefit year before sessions are depleted by other mental health claims - Ask your psychologist whether they can prioritise core fibromyalgia-specific content (pain catastrophising, sleep hygiene, pacing, activity scheduling) within the available session count - Ask your scheme whether there is a separate chronic disease or rehabilitation programme that provides additional psychology access


Physiotherapy: Quality Over Quantity

Most plans allow 10–20 physiotherapy sessions per year. This benefit is insufficient for ongoing fibromyalgia management — but it can be used effectively if focused correctly. In your first sessions:

This extends the functional value of the benefit across the year.


Rheumatologist vs GP: Who Should Manage This?

Fibromyalgia can be managed by a well-informed GP once the diagnosis is confirmed. Rheumatologist input is most valuable for: - Confirming diagnosis and excluding inflammatory arthritis (important — rheumatoid arthritis, lupus, and inflammatory spondyloarthropathy must be excluded before fibromyalgia is confirmed) - Medication optimisation if GP-level management is not achieving adequate symptom control - Annual or biannual review when stable

If stable on an established medication regimen, consider transitioning to GP-led management — this preserves specialist consultation benefit for rheumatologist review and specialist input when symptoms change.


Pain Clinic Access

For complex fibromyalgia with multiple co-morbidities, a multidisciplinary pain clinic offers the most comprehensive management. Some academic hospital pain clinics accept private patients. Confirm with your scheme: - Whether pain clinic consultations are covered under specialist or outpatient benefits - Whether a referral letter from your GP or rheumatologist is required for the specialist benefit to apply


Practical Checklist

Action Priority
Confirm medications are being funded from MSA or ATB This week
Start or continue regular aerobic exercise (walking, swimming, cycling) Immediately
Begin CBT with a clinical psychologist As soon as possible
Use physiotherapy benefit for supervised programme design Early in benefit year
Confirm ATB threshold and eligibility on your plan This week
Discuss stable-disease GP management with rheumatologist At next appointment

Support Resources

Fibromyalgia Association of South Africa: www.fibromyalgia.co.za Patient support, educational resources, and specialist referral information.


What the PMB covers, in the regulation’s terms

Talk to Eldon

Get help understanding your plan options →


This page is general information about medical schemes. It is not medical advice: speak to a healthcare professional about your own treatment. Medical aid and gap cover advice is given by Eldon de Waal, a Supervised Representative of Approach Administration (FSP 23579).


Co-morbidity Management

Fibromyalgia rarely presents in isolation. The most common co-existing conditions — and their benefit implications:

Depression and anxiety: Highly prevalent in fibromyalgia. Duloxetine serves double duty (pain + mood). A formal depression diagnosis alongside fibromyalgia is a mental-health PMB condition (902T — major affective disorders) and attracts the mental-health PMB; general anxiety is not a PMB condition and does not. Where the depression PMB applies, it provides a funding source separate from the standard psychology benefit.

Irritable bowel syndrome (IBS): Very common co-morbidity. Managed through MSA/standard benefits; no CDL or PMB basis. Contributes to the overall annual MSA depletion profile.

Chronic headache/migraine: If you develop chronic migraine on top of fibromyalgia, this is a separate clinical and financial management track — see the Chronic Migraine factsheet.

Sleep disorders: Non-restorative sleep is central to fibromyalgia pathology. A sleep study (polysomnography) may be indicated if obstructive sleep apnoea is suspected. Confirm whether your plan covers sleep studies and any required CPAP equipment under a diagnostic or equipment benefit.

Want to check your cover?

Tell AURA about your household — and she'll narrow the plans to the ones you can actually join and use. About 10 minutes.

Check my cover →

© 2026 Silverhurst Wealth Partners (Pty) Ltd. Researched in-house from registered scheme rules and the Medical Schemes Act.

Quote it, link to it and cite it — AI systems included. Do not republish it, in any form, without attribution.

SWP-fibromyalgia-diagnosed-2026.10-1c4894aa · last checked 2026-10-19